item management s discussion and analysis of financial condition and results of operations for the three years ended december   and results of operations net income loss in the company incurred a net loss of  compared to net income of  in and  in income before income taxes and unusual items increased to  in compared to  in and  in income  including unusual items and before income taxes was  in compared to  in and  in income before income taxes in includes a charge to earnings of  related to the restructuring of the company s non allograft operations located in leiden  the netherlands 
income before income taxes in includes the receipt of note repayments on a fully reserved note from a major customer of  and a charge to earnings of  resulting from the termination of a distribution agreement for trauma implant products 
see provision for restructuring and provision for termination of a distribution agreement included elsewhere herein 
income tax expense in and was reduced by the recognition of net deferred tax assets resulting primarily from the realization of tax benefits associated with federal and state tax net operating loss carryforwards 
see income tax provision benefit  net included elsewhere herein 
the table below shows the impact of these items income before income taxes and unusual items    unusual items provision for restructuring  note repayments from major customer  provision for termination of distribution  agreement income before income taxes    recognition of net deferred tax assets   income tax provision    net income loss    the following is a discussion of factors which affected results of operations for the years ended december   and net revenues revenues in increased to  from  in revenues in were higher than revenues of  the increase in revenues in resulted principally from increased demand for the company s grafton dbm gel and the introduction of grafton dbm flex in january and grafton dbm putty in november the increase in revenues in resulted principally from increased demand for grafton dbm gel and ceramic hydroxyapatite powders distributed by the company 
supporting the company s grafton dbm expansion is a national network of independent agencies that manage surgeon relationships in partnership with the company s direct field marketing organization 
at december   the network consisted of agencies with representatives compared to agencies with representatives at december  during  and  two of the company s major customers  mtf and arc  accounted for and  and  and and  respectively  of revenues 
in december  the company entered into a new ten year agreement with arc 
the company is currently in negotiations with mtf for a new agreement to replace the existing agreement which expires on march  there can be no assurance that the company and mtf will enter into a new agreement or that such agreement will contain terms favorable to the company 
the loss of either mtf or arc as a customer would have a material adverse effect on the company 
costs of services and products costs of services as a percentage of service revenues was in  in and in these declines in costs as a percentage of revenues result from a shift in revenue mix toward services with higher gross margins and fixed processing costs being distributed over a higher volume of donors processed 
costs of products as a percentage of product revenues was in  in and in the increase in costs as a percentage of revenues resulted principally from an increase in product liability insurance premiums associated with spinal implant products distributed by the company pursuant to an agreement with ulrich  the manufacturer 
marketing  general and administrative expenses marketing  general and administrative expenses increased  or in and  or in these increases are primarily attributable to expanded marketing activities associated with the increased allograft services provided by the company  principally those related to grafton dbm  and increased facilities costs resulting from an expansion of the company s facilities to support growth 
marketing  general and administrative expenses declined as a percentage of revenues in each year from in to in and in research and development expenses research and development expenses in increased  or to  from  in research and development expenses in increased  or compared to  in the increases in both years were primarily attributable to increased spending associated with the development of additional allograft tissue forms which were introduced into the market during  expansion of the company s viral inactivation process to a broader range of allograft tissue and the development of polyactive r products 
see provision for restructuring 
provision for restructuring in october  the company announced a plan to restructure its non allograft operations located in leiden  the netherlands in order to focus those operations on i the revenue and profit generating activities of providing ceramic and titanium spray coating services and ceramic products to the orthopaedic and dental markets and ii to pursue oem business opportunities for those technologies 
in connection with the restructuring  the company discontinued its polyactive polymer research and development program 
as a result of the restructuring  the company recorded a pre tax restructuring charge of  consisting primarily of employee termination costs  write off of equipment  intangible assets  supplies and costs associated with the planned sub leasing of office space in leiden on which the company has a long term lease 
see note of notes to consolidated financial statements 
provision for termination of distribution agreement in june  the company terminated its distribution agreement for trauma implant products with its supplier  aap  gmbh  of berlin  germany 
as a result of this termination the company recorded a pre tax charge to earnings of  consisting principally of inventory write offs  employee termination costs and legal fees 
the company has commenced legal proceedings to recover these costs 
revenues from marketing trauma products were not material in see note of notes to consolidated financial statements 
other income expense in  other income decreased by  compared to other income in included the receipt of  of note repayments on a fully reserved note from a major customer 
see note of notes to consolidated financial statements 
income tax provision benefit  net the income tax provision in each of the years reflects a rate in excess of the federal statutory income tax rate due to state income taxes and foreign losses for which no current tax benefits would be available 
in and  the company recognized net deferred tax assets of  and  respectively  resulting from i the realization of tax benefits of temporary differences which reversed during each year  in and  in  and ii the company s assessment that it would generate sufficient future us taxable income to realize a portion of the deferred tax benefits associated with certain federal and state net operating loss carryforwards and tax credits  in and  in 
see note of notes to consolidated financial statements 
liquidity and capital resources at december   the company had cash and short term investments of  compared to  at december  working capital increased  to  at december  compared to  at december  the company has a loan and security agreement with a us bank which provides for borrowings of up to  under a revolving line of credit and  under an equipment line of credit 
at december    was outstanding under the equipment line of credit and there were no borrowings outstanding under the revolving line of credit 
the company also has a line of credit with a dutch bank which provides for borrowings of up to  dfl  or approximately  at the december  exchange rate 
analysis of the company s cash position and anticipated cash flow indicated that it most likely would not be necessary to utilize a significant portion of this line of credit in and  therefore  the company agreed with the bank to limit its borrowings in  if any  to no more than  dfl  or approximately  at the december  exchange rate 
additionally  in connection with the leiden facility lease  the company is required to maintain a declining bank guarantee which reduced the current amount available for borrowings to  dfl  or approximately  at the december  exchange rate 
at december   there were no borrowings outstanding under this credit line 
see note of notes to consolidated financial statements 
at december   the company had us net operating loss carryforwards which approximate  for federal income tax purposes and  for state income tax purposes 
the federal and state net operating loss carryforwards  if unused  will expire from through the company also has research and development tax credits for federal income tax purposes of  which expire in the timing and manner in which the tax loss carryforwards and credits are utilized in the future may be limited by internal revenue code section in addition  certain of the company s subsidiaries have foreign net operating loss carryforwards aggregating   with no expiration date   expiring through 
see note of notes to consolidated financial statements 
during the company incurred capital expenditures of  to support the expansion of the company s operations 
although the company had no significant commitments for capital expenditures as of december   it expects capital expenditures to be approximately higher than those of it is expected that these expenditures will be funded from cash reserves  cash provided by operations or bank financing 
the company believes that its cash and cash equivalents  short term investments and available lines of credit  together with anticipated cash flow from operations will be sufficient to meet its near term requirements  but may not be adequate to fully develop and commercialize all products currently under development by the company 
further  from time to time  the company may seek additional funds through equity or debt financing 
however  there can be no assurance that such additional funds will be available to the company  or if available  that such funds will be available on terms favorable to the company 

